bioAffinity Technologies Q2 EPS $(0.17) Misses $(0.10) Estimate, Sales $1.269M Miss $1.506M Estimate

bioAffinity Technologies (NASDAQ: BIAF) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.10) by 70 percent. This is a 10.53 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $1.269 million which missed the analyst consensus estimate of $1.506 million by 15.74 percent. This is a 47.08 percent decrease over sales of $2.398 million the same period last year.